Skip to main content
Log in

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

The co-administration of antiepileptic drugs (AED) and chemotherapeutic agents in patients with glioblastoma multiforme (GBM) is common. Interactions of chemotherapeutic agents and AED have not been investigated sufficiently. The purpose of this study is to evaluate the effects of enzyme inducing (EI-AED) and non-EI-AED in patients with GBM treated with standard chemotherapeutic agents on survival and haematotoxicity. One hundred and sixty eight glioblastoma patients with standard treatment including surgery, radiotherapy and chemotherapy were retrospectively analysed. Patients were separated into three groups: Group A patients without AED (n=88), Group B patients with EI-AED (n=43), and Group C patients with non-EI-AED (n=37). CCNU was the most frequently used first-line drug in all three groups (Group A: 77%; Group B: 81%; Group C: 78%). Second line treatment, mainly temozolomide, was applicated in 58 of patients and third-line treatment in 9. Carbamazepine was the most frequently administered AED in Group B (81%) and valproic acid in Group C (85%). For statistical analysis, only patients with CCNU first line treatment were calculated. A significant difference regarding survival was detected between Group B (10.8 month) and Group C (13.9 month), as well as increased haematotoxicity for Group C. These results indicate that AED influence the pharmacokinetics of chemotherapeutic drugs in patients with GBM. Valproic acid might be responsible for increasing haematotoxicity. Whether the difference regarding survival between Group B and Group C is due to a decrease of efficacy of chemotherapeutic agents by EI-AED, or due to increased efficacy of chemotherapeutic agents caused by the enzyme inhibiting properties of valproic acid, has to be evaluated in future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. AA Brandes F Vistola U Basso F Berti G Pinna A Rotilio M Gardiman R Scienza S Monfardini M. Ermani (2003) ArticleTitleA prospective study on glioblastoma in the elderly Cancer 1 657–662 Occurrence Handle10.1002/cncr.11097

    Article  Google Scholar 

  2. EL Chang W Yi PK Allen VA Levin RE Sawaya MH. Maor (2003) ArticleTitleHypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors Int J Radiat Oncol Biol Phys 56 519–528 Occurrence Handle10.1016/S0360-3016(02)04522-4 Occurrence Handle12738329

    Article  PubMed  Google Scholar 

  3. X Durando JJ Lemaire J Tortochaux I Van-Praagh F Kwiatkowski C Vincent C Bailly P Vergelle B Irthum J Chazal JO. Bay (2003) ArticleTitleHigh-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients Bone Marrow Transplant 3 559–564 Occurrence Handle10.1038/sj.bmt.1703889

    Article  Google Scholar 

  4. SA Grossman A O’Neil M Grunnet M Mehta JL Pearlman H Wagner M Gilbert HB Newton R. Hellman (2003) ArticleTitleEastern Cooperative Oncology Group. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 15 1485–1491 Occurrence Handle10.1200/JCO.2003.10.035

    Article  Google Scholar 

  5. IV Pech K Peterson JG. Cairncross (1998) ArticleTitleChemotherapy for brain tumors Oncology. 12 537–543 Occurrence Handle1:STN:280:DyaK1c3js1Cnsg%3D%3D Occurrence Handle9575527

    CAS  PubMed  Google Scholar 

  6. S Trippoli F Pelagotti A Messori F Vacca M Vaiani S. Maltoni (2003) ArticleTitleSurvival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study Drugs R D 4 285–291 Occurrence Handle1:CAS:528:DC%2BD3sXosFChtro%3D Occurrence Handle12952497

    CAS  PubMed  Google Scholar 

  7. R Stupp PY Dietrich S Kraljevic A Pica I Maillard P Maeder R Meuli R Panzer G Pizzolato R Miralbell F Porchet L Regli N Tribolet Particlede RO Mirimanoff S. Leyvraz (2002) ArticleTitlePromising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 1 1375–1382 Occurrence Handle10.1200/JCO.20.5.1375

    Article  Google Scholar 

  8. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jaaskelainen Z. Ram (2003) ArticleTitleA phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-oncol 5 79–88 Occurrence Handle1:CAS:528:DC%2BD3sXjtVKltL4%3D Occurrence Handle12672279

    CAS  PubMed  Google Scholar 

  9. PL Moots RJ Maciunas DR Eisert RA Parker K Laporte B. Abou-Khalil (1995) ArticleTitleThe course of seizure disorders in patients with malignant gliomas Arch Neuro 52 717–724 Occurrence Handle1:STN:280:ByqA2cvjsVQ%3D Occurrence Handle7619029

    CAS  PubMed  Google Scholar 

  10. Greenberg HS, Chandler WF, Sandler HM. (1999). Brain Tumors. Contemporary Neurology Series. Oxford University Press. 299–317.

  11. K Lote AE Stenwig K Skullerud H. Hirschberg (1998) ArticleTitlePrevalence and prognostic significance of epilepsy in patients with gliomas Eur J Cancer 34 98–102 Occurrence Handle10.1016/S0959-8049(97)00374-2 Occurrence Handle1:STN:280:DyaK1c3oslejuw%3D%3D Occurrence Handle9624245

    Article  CAS  PubMed  Google Scholar 

  12. S Oberndorfer T Schmal H Lahrmann S Urbanits K Lindner W. Grisold (2002) ArticleTitleThe frequency of seizures in patients with primary brain tumors or cerebral metastasis Wien Klin Wochenschr 30 911–916

    Google Scholar 

  13. PN Patsalos E. Perucca (2003) ArticleTitleClinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs Lancet Neurol 2 347–356 Occurrence Handle10.1016/S1474-4422(03)00409-5 Occurrence Handle1:CAS:528:DC%2BD3sXms1yrtbw%3D Occurrence Handle12849151

    Article  CAS  PubMed  Google Scholar 

  14. PN Patsalos E. Perucca (2003) ArticleTitleClinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs Lancet Neurol 2 473–481 Occurrence Handle10.1016/S1474-4422(03)00483-6 Occurrence Handle1:CAS:528:DC%2BD3sXmslamtbs%3D Occurrence Handle12878435

    Article  CAS  PubMed  Google Scholar 

  15. KT Kivisto HK Kroemer M. Eichelbaum (1995) ArticleTitleThe role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions Br J Clin Pharmacol 40 523–530 Occurrence Handle1:STN:280:BymB2cjgt1E%3D Occurrence Handle8703657

    CAS  PubMed  Google Scholar 

  16. CJ Vecht GL Wagner EB. Wilms (2003) ArticleTitleInteractions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404–409 Occurrence Handle10.1016/S1474-4422(03)00435-6 Occurrence Handle1:CAS:528:DC%2BD3sXms1yhsLk%3D Occurrence Handle12849118

    Article  CAS  PubMed  Google Scholar 

  17. MG Neuman NH Shear PM Jacobson-Brown GG Katz HK Neilson IM Malkiewicz RG Cameron F. Abbott (2001) ArticleTitleCYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity Clin Biochem 34 211–218 Occurrence Handle10.1016/S0009-9120(01)00217-X Occurrence Handle1:CAS:528:DC%2BD3MXltl2hu74%3D Occurrence Handle11408019

    Article  CAS  PubMed  Google Scholar 

  18. PN Patsalos W Froscher F Pisani CM. Rijn Particlevan (2002) ArticleTitleThe importance of drug interactions in epilepsy therapy Epilepsia 43 365–385 Occurrence Handle10.1046/j.1528-1157.2002.13001.x Occurrence Handle1:CAS:528:DC%2BD38XjtlSlur8%3D Occurrence Handle11952767

    Article  CAS  PubMed  Google Scholar 

  19. V Bourg C Lebrun RM Chichmanian P Thomas M. Frenay (2001) ArticleTitleNitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity Ann Oncol 12 217–219 Occurrence Handle10.1023/A:1008331708395 Occurrence Handle1:STN:280:DC%2BD3M3gvFantA%3D%3D Occurrence Handle11300327

    Article  CAS  PubMed  Google Scholar 

  20. VA Levin J Stearns A Byrd A Finn RJ. Weinkam (1979) ArticleTitleThe effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU J Pharmacol Exp Ther 208 1–6 Occurrence Handle1:CAS:528:DyaE1MXhtlarsbk%3D Occurrence Handle759602

    CAS  PubMed  Google Scholar 

  21. PJ Muller CH Tator ML. Bloom (1983) ArticleTitleUse of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice Cancer Res 43 2068–2071 Occurrence Handle1:CAS:528:DyaL3sXktVShsbs%3D Occurrence Handle6831437

    CAS  PubMed  Google Scholar 

  22. World Health Organization: International Histological Classification of Toumors. Histological Typing of Tumours of the Central Nervous Sysrem. Geneva, WHO, No 2, 1979

  23. JC Buckner JM Reid K Wright SH Kaufmann C Erlichman M Ames S Cha JR O’Fallon LJ Schaaf LL. Miller (2003) ArticleTitleIrinotecan in the treatment of glioma patients: current and future studies on the north central cancer treatment group Cancer 97 2352–2358 Occurrence Handle10.1002/cncr.11304 Occurrence Handle1:CAS:528:DC%2BD3sXjvVSgsrg%3D Occurrence Handle12712456

    Article  CAS  PubMed  Google Scholar 

  24. TF Cloughesy E Filka J Kuhn G Nelson F Kabbinavar H Friedman LL Miller GL. Elfring (2003) ArticleTitleTwo studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen Cancer 97 2381–2386 Occurrence Handle10.1002/cncr.11306 Occurrence Handle1:CAS:528:DC%2BD3sXjvVSgs74%3D Occurrence Handle12712460

    Article  CAS  PubMed  Google Scholar 

  25. MR Fetell SA Grossman JD Fisher B Erlanger E Rowinsky J Stockel S. Piantadosi (1997) ArticleTitlePreirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions New Approaches to Brain Tumor Therapy Central Nervous System Consortium. J Clin Oncol 15 3121–3128 Occurrence Handle1:CAS:528:DyaK2sXmt1Sqtrs%3D Occurrence Handle9294475

    CAS  PubMed  Google Scholar 

  26. HS Friedman WP Petros AH Friedman LJ Schaaf T Kerby J Lawyer M Parry PJ Houghton S Lovell K Rasheed T Cloughsey ES Stewart OM Colvin JM Provenzale RE McLendon DD Bigner I Cokgor M Haglund J Rich D Ashley J Malczyn GL Elfring LL. Miller (1999) ArticleTitleIrinotecan therapy in adults with recurrent or progressive malignant glioma J Clin Oncol 17 1516–1525 Occurrence Handle1:CAS:528:DyaK1MXjsF2ms7o%3D Occurrence Handle10334539

    CAS  PubMed  Google Scholar 

  27. SA Grossman F Hochberg J Fisher TL Chen L Kim R Gregory LB Grochow S. Piantadosi (1998) ArticleTitleIncreased 9-aminocamptothecin dose requirements in patients on anticonvulsants NABTT CNS Consortium. The new approaches to brain tumor therapy. Cancer Chemother Pharmacol 42 118–126 Occurrence Handle10.1007/s002800050794 Occurrence Handle1:CAS:528:DyaK1cXjslWmur0%3D Occurrence Handle9654111

    Article  CAS  PubMed  Google Scholar 

  28. RA. Kramer (1999) ArticleTitleCytochrome P450-inducing antiepileptics increase the clearence of vincristine in patients with brain tumors Clin Pharmocol Ther 66 589–593

    Google Scholar 

  29. JG. Kuhn (2002) ArticleTitleInfluence of anticonvulsants on the metabolism and elimination of irinotecan A North American Brain Tumor Consortium preliminary report. Oncology 16 33–40

    Google Scholar 

  30. E Raymond M Fabbro V Boige O Rixe M Frenay G Vassal S Faivre E Sicari C Germa JM Rodier L Vernillet JP. Armand (2003) ArticleTitleMulticentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastoma Ann Oncol 14 603–614 Occurrence Handle1:STN:280:DC%2BD3s7jsVSisw%3D%3D Occurrence Handle12649109

    CAS  PubMed  Google Scholar 

  31. Hildebrand J, Michael Brada (eds). Epileptic seizures. In: Differential Diagnosis in Neuro-oncology. Oxford University Press, 2001, pp 47–58

  32. MJ. Vanden Bent (2003) ArticleTitleThe role of chemotherapy in brain metastases Eur J Cancer 39 2114–2120 Occurrence Handle1:CAS:528:DC%2BD3sXns1KlsLs%3D Occurrence Handle14522368

    CAS  PubMed  Google Scholar 

  33. DF Smith JL Hutton D Sandemann PM Foy MD Shaw IR Williams DW. Chadwick (1991) ArticleTitleThe prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management J Neurol Neurosurg Psychiatry 54 915–920 Occurrence Handle1:STN:280:By2D2sfpsVQ%3D Occurrence Handle1744647

    CAS  PubMed  Google Scholar 

  34. K Villikka KT Kivisto H Maenpaa H Joensuu PJ. Neuvonen (1999) ArticleTitleCytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors Clin Pharmacol Ther 66 589–593

    Google Scholar 

  35. AE Ahmed M Grissom R El-Azhary A Haque PJ Boor J. Costanzi (1987) ArticleTitleStudies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. II. Biochemical and morphological characterization of the injury and its prevention by phenobarbital Cancer Chemother Pharmacol 19 103–108 Occurrence Handle1:CAS:528:DyaL1cXjtFCrtQ%3D%3D Occurrence Handle3105904

    CAS  PubMed  Google Scholar 

  36. PJ McKee J Blacklaw E Butler RA Gillham MJ. Brodie (1992) ArticleTitleVariability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients Epilepsy Res 11 193–198 Occurrence Handle1:STN:280:ByyD3M%2FptFE%3D Occurrence Handle1396534

    CAS  PubMed  Google Scholar 

  37. E. Perucca (2001) ArticleTitleClinical pharmacology and therapeutic use of the new antiepileptic drugs Fundam Clin Pharmacol 15 405–417 Occurrence Handle1:CAS:528:DC%2BD38Xht1Kqt7w%3D Occurrence Handle11860529

    CAS  PubMed  Google Scholar 

  38. E Perucca S Hebdige GM Frigo G Gatti S Lecchini A. Crema (1980) ArticleTitleInteraction between phenytoin and valproic acid: plasma protein binding and metabolic effects Clin Pharmacol Ther 28 779–789 Occurrence Handle1:CAS:528:DyaL3MXns1Gjuw%3D%3D Occurrence Handle6777108

    CAS  PubMed  Google Scholar 

  39. E Perucca O Dulac S Shorvon T. Tomson (2001) ArticleTitleHarnessing the clinical potential of antiepileptic drug therapy: dosage optimisation CNS Drugs 15 609–621 Occurrence Handle1:CAS:528:DC%2BD3MXntlant70%3D Occurrence Handle11524033

    CAS  PubMed  Google Scholar 

  40. EE Samara RG Granneman GF Witt JH. Cavanaugh (1997) ArticleTitleEffect of valproate on the pharmacokinetics and pharmacodynamics of lorazepam J Clin Pharmacol 37 442–450 Occurrence Handle1:CAS:528:DyaK2sXjs1Cnsbs%3D Occurrence Handle9156377

    CAS  PubMed  Google Scholar 

  41. TK Chang H Chen DJ. Waxman (1994) ArticleTitle1-(2-chloroethyl)-3-cyclohexyl-1-nitrosurea (CCNU modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 “C11 messenger RNA levels Drug Metab Dispos 22 673–679 Occurrence Handle1:CAS:528:DyaK2cXmsVGntr0%3D Occurrence Handle7835216

    CAS  PubMed  Google Scholar 

  42. CL. Litterst (1981) ArticleTitleProlonged depression of hepatic microsomal drug metabolism and hemoprotein levels following a single dose of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) Biochem Pharmacol 30 1014–1016 Occurrence Handle1:CAS:528:DyaL3MXkvFSqsbo%3D Occurrence Handle7236311

    CAS  PubMed  Google Scholar 

  43. S Tong Y Hirokata CL Litterst TE. Gram (1984) ArticleTitleInteraction of the oncolytic drug, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea with the mixed-function oxidase system in rats Chem Biol Interact 49 105–119 Occurrence Handle1:CAS:528:DyaL2cXktlaqsL0%3D Occurrence Handle6722931

    CAS  PubMed  Google Scholar 

  44. C Liddle BJ Goodwin J George M Tapner GC. Farrell (1998) ArticleTitleSeparate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes J Clin Endocrinol Meta 83 2411–2416 Occurrence Handle1:CAS:528:DyaK1cXksVSisr8%3D

    CAS  Google Scholar 

  45. TE. Lackner (1991) ArticleTitleInteraction of dexamethasone with phenytoin Pharmacotherapy 11 344–347 Occurrence Handle1:STN:280:By2D38%2FjsVw%3D Occurrence Handle1923918

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Oberndorfer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberndorfer, S., Piribauer, M., Marosi, C. et al. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72, 255–260 (2005). https://doi.org/10.1007/s11060-004-2338-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-2338-2

Keywords

Navigation